The role of methemoglobin and carboxyhemoglobin in COVID-19: a review
Following the outbreak of a novel coronavirus (SARS-CoV-2) associated with pneumonia in
China (Corona Virus Disease 2019, COVID-19) at the end of 2019, the world is currently …
China (Corona Virus Disease 2019, COVID-19) at the end of 2019, the world is currently …
Elucidating the mechanisms and efficacy of antimalarial drugs in Systemic lupus erythematosus
D Paredes-Ruiz, D Martin-Iglesias, L Amo… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction Antimalarials (AMs) are old drugs with a wide range of beneficial
effects in systemic lupus erythematosus (SLE) beyond the control of activity. The most recent …
effects in systemic lupus erythematosus (SLE) beyond the control of activity. The most recent …
G6PD Deficiency and COVID-19 in Burkina Faso: a possible link?
AK Ouattara, L Traoré, TR Compaoré… - Journal of Biosciences …, 2023 - scirp.org
Burkina Faso is a malaria-endemic country, with a high incidence of G6PD deficiency
(G6PDd), which recorded its first case of COVID-19 in March 2020. G6PDd leads to a …
(G6PDd), which recorded its first case of COVID-19 in March 2020. G6PDd leads to a …
[HTML][HTML] Hydroxychloroquine Therapy and G6PD Genotype
M Kane - 2023 - europepmc.org
Hydroxychloroquine, which is closely related to chloroquine, can be used for the prevention
and treatment of some forms of malaria and rheumatic conditions such as systemic lupus …
and treatment of some forms of malaria and rheumatic conditions such as systemic lupus …
[PDF][PDF] Covid-19-G6PD deficiency and hydroxychloroquine
VM dos Santos, LC Modesto… - Revista Electrónica de …, 2019 - biomed.uninet.edu
G6PD deficiency increased in interest during the Covid-19 pandemic, due to the
hydroxychloroquine (HCQ) utilization for early treatment1-8. Mutations in the g6pdx gene of …
hydroxychloroquine (HCQ) utilization for early treatment1-8. Mutations in the g6pdx gene of …